期刊文献+

血清和血浆中血栓蛋白差异的研究 被引量:3

Initial investigation of proteomic differences between serum and plasma
下载PDF
导出
摘要 目的:研究血清与血浆中血栓蛋白的差异,探索临床检验血标本的最佳取材方式。方法:采用表面增强激光解吸/离子化飞行时间质谱(SELDI-TOF-MS)技术,并选用CM10蛋白质芯片对8名志愿者的血清和血浆标本分别进行检测,经Proteinchip Software 3.2软件采集原始数据后,采用Ciphergen公司的Biomarker Wizard软件分析血清及血浆标本中所有质荷比(m/z)蛋白丰度的差异,以初步探讨血清和血浆中血栓蛋白的差异。结果:经Biomarker Wizard软件分析,显示2类标本间共有18个蛋白丰度有显著性差异,其中m/z为1872、1902、1923、1993、2144、2193、2745、3402、15147的9个蛋白在血浆中含量较高,而m/z为3162、4097、4215、5645、5913、7774、8150、8924、9299的9个蛋白在血浆中含量较低。结论:血清和血浆间存在许多血栓蛋白丰度的差异。因此,在临床检验血液中血栓蛋白时,为尽可能反映血液非细胞成分的在体特征,标本选择血浆可能更佳。 Objective To study proteomic differences between serum and plasma for selecting the optimal specimen in proteomic research and laboratory testing.Methods Surface enhanced laser desorption/ionization time-of-flight mass spectrometry(SELDI-TOF-MS) CM10 Proteinchip technology was used to detect eight serum and plasma samples.Raw data was collected by Proteinchip Software 3.2 and then Biomarker Wizard software was used to compare all protein peaks between serum and plasma.Results Eighteen protein peaks were significantly different between the serum and plasma samples.Among them,the concentration of 9 proteins with the key mass/charge(m/z) values 1 872,1 902,1 923,1 993,2 144,2 193,2 745,3 402 and 15 147 were significantly higher in the plasma than that in the serum;while the concentration of 9 proteins with the key m/z values 3 162,4 097,4 215,5 645,5 913,7 774,8 150,8 924 and 9 299 were dramatically lower in the plasma.Conclusions Compared with plasma,there are many significantly different protein peaks in serum samples;plasma should be used to maintain concordance with the body and reflect the real state of cell-free component in blood when performing proteomic studies and laboratory testing.
作者 王静 张小为
出处 《诊断学理论与实践》 2007年第4期323-326,共4页 Journal of Diagnostics Concepts & Practice
基金 国家自然科学基金(39970763 30471807)
关键词 血清 血浆 蛋白质组学 差异 表面增强激光解吸/离子化飞行时间质谱 Serum Plasma Proteomics Differences Surface enhanced laser desorption/ionization time-of-flight mass spectrometry
  • 相关文献

参考文献7

  • 1[1]Rudstein-Svetlicky N,Loewenthal R,Horejsi V,et al.HLA-G levels in serum and plasma[J].Tissue Antigens,2007,69(Suppl 10):140-142.
  • 2[2]Wu CY,Wu MS,Chiang EP,et al.Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution[J].Clin Cancer Res,2007,13(7):2054-2060.
  • 3贺石林,葛金文.凝血与临床检验中血标本的选择[J].诊断学理论与实践,2005,4(6):513-516. 被引量:8
  • 4[4]Thadikkaran L,Siegenthaler MA,Crettaz D,et al.Recent advances in blood-related proteomics[J].Proteomics,2005,5(12):3019-3034.
  • 5[5]Omenn GS,States DJ,Adamski M,et al.Overview of the HUPO Plasma Proteome Project:results from the pilot phase with 35 collaborating laboratories and multiple analytical groups,generating a core dataset of 3020 proteins and a publicly-available database[J].Proteomics,2005,5(13):3226-3245.
  • 6张雪群,姜颖,厉有名,贺福初.人血浆低丰度蛋白富集方法的研究进展[J].中华检验医学杂志,2006,29(10):947-950. 被引量:9
  • 7贺石林,葛金文.正确选择血标本的思考[J].诊断学理论与实践,2005,4(6):433-434. 被引量:7

二级参考文献64

  • 1张卉,贺蓉,贺石林.炎症与血栓形成[J].中华医学杂志,2004,84(9):784-786. 被引量:29
  • 2王东生,陈方平,贺石林,解勤之,付斌,李昕,曹星玉,陈焱.大黄虫丸血浆药理学与血清药理学作用的比较研究[J].血栓与止血学,2005,11(1):5-8. 被引量:34
  • 3贺石林,葛金文,贺蓉,梅志刚.质疑血清药理学,加强多层次半体内实验研究[J].中国药理学通报,2005,21(3):277-279. 被引量:32
  • 4贺石林,葛金文.凝血与临床检验中血标本的选择[J].诊断学理论与实践,2005,4(6):513-516. 被引量:8
  • 5[2]Ebert SC,Leroy M,Darcey B.Comparison of aminoglycoside concentrations measured in plasma versus serum[J].Ther Drug Monit,1989,11(1):44-46.
  • 6[3]Gaussem P,Reny JL,Thalamas C,et al.The specific thromboxane receptor antagonist S 18886:pharmacokinetic and pharmacodynamic studies [J].J Thromb Haemost,2005,3(7):1437-1445.
  • 7[4]Nosanchuk JS,Combs B,Abbott G.False increases of troponin I attributable to incomplete separation of serum[J].Clin Chem,1999,45(5):714.
  • 8[5]Stiegler H,Fischer Y,Vazquez-Jimenez JF,et al.Lower cardiac troponin T and I results in heparin-plasma than in serum[J].Clin Chem,2000,46(9):1338-1344.
  • 9[6]Wu AH,Apple FS,Gibler WB,et al.National Academy of Clinical Biochemistry Standards of Laboratory Practice:recommendations for the use of cardiac markers in coronary artery diseases [J].Clin Chem,1999,45(7):1104-1121.
  • 10[1]WHO,Use of anticoagulants in diagnostic investigations.WHO/DIL/LAB/99.1 Rev.2,2002.

共引文献18

同被引文献70

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部